Promoter Analysis and Chromosomal Mapping of Human EBAG9 Gene

The human EBAG9 was previously identified as an estrogen responsive gene using CpG-genomic binding site cloning (Watanate et al., (1998) Mol. Cell. Biol. 18: 442–449). Recently it was revealed that the EBAG9 is identical with RCAS1 which is a cancer cell surface antigen implicated in immune escape....

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2000-07, Vol.273 (2), p.654-660
Main Authors: Ikeda, Kazuhiro, Sato, Masako, Tsutsumi, Osamu, Tsuchiya, Fujiko, Tsuneizumi, Michiko, Emi, Mitsuru, Imoto, Issei, Inazawa, Johji, Muramatsu, Masami, Inoue, Satoshi
Format: Article
Language:English
Subjects:
Base Sequence
Binding Sites - genetics
cancer
Chromosome Mapping
Chromosomes, Human, Pair 8 - genetics
DNA - genetics
DNA - metabolism
DNA Primers - genetics
EBAG9
estrogen
estrogen receptor
Estrogen Receptor alpha
estrogen responsive element
Estrogens - metabolism
FISH
Humans
In Situ Hybridization, Fluorescence
Molecular Sequence Data
Promoter Regions, Genetic
Receptors, Estrogen - metabolism
transcriptional regulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The human EBAG9 was previously identified as an estrogen responsive gene using CpG-genomic binding site cloning (Watanate et al., (1998) Mol. Cell. Biol. 18: 442–449). Recently it was revealed that the EBAG9 is identical with RCAS1 which is a cancer cell surface antigen implicated in immune escape. Here, we isolated and analyzed the 5′-flanking region of human EBAG9 gene. We determined transcription initiation site, which has a homology with an initiator element YYCAYYYY, and found that TATA motif was absent. Deletion analysis of the 5′-flanking region using MCF-7 breast cancer cells indicated that the sequences −86 to −36 containing the ERE had the basal level of promoter activity and the upstream GC-rich region positively regulated the activity. EBAG9 promoter luciferase reporters containing the ERE could respond to estrogen, and electrophoretic mobility shift assay showed that ERα bound to the ERE. Moreover, fluorescent in situ hybridization analysis has shown that the human EBAG9 gene is located at chromosome 8q23 which is frequently amplified in tumors. These findings suggest that the human EBAG9 might be involved in carcinogenesis as an estrogen responsive gene.
ISSN:0006-291X
1090-2104
DOI:10.1006/bbrc.2000.2920